Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease
- 5 December 2002
- journal article
- clinical trial
- Published by Wiley in Movement Disorders
- Vol. 18 (3), 287-293
- https://doi.org/10.1002/mds.10390
Abstract
We assessed the safety and efficacy of modafinil for the treatment of excessive daytime sleepiness in patients with Parkinson's disease (PD). This was a single‐site, randomized, double‐blind, placebo‐controlled crossover study of 21 PD patients having an Epworth Sleepiness Scale (ESS) score ≥10. They received either placebo or modafinil 200 mg/day for 3 weeks, followed by a washout week, then the alternate treatment for 3 weeks. The ESS data demonstrated a carryover effect, so the changes from baseline ESS scores were compared between the two treatments for period 1 only. The ESS scores for the placebo group went from 16.0 ± 4.2 (mean ± SD) to 17.0 ± 5.1 and for the modafinil group went from 17.8 ± 4.2 to 14.4 ± 5.7 (P = 0.039). There was no significant carryover effect for any other measure. The patient Clinical Global Impression of Change (+3 to −3) improved by 0.75 on modafinil compared with 0.15 for placebo (P = 0.07). A total of 7 of 20 (35%) of the patients reported some improvement on modafinil but not placebo. There was no significant improvement or worsening of the UPDRS subscores I–III, Timed Tap test, or time on. Vital signs, electrocardiograms, and lab tests were unchanged. Modafinil was very well tolerated. Our data demonstrate that, in a small sample size, administration of 200 mg/day of modafinil was associated with few side effects and was modestly effective for the treatment of excessive daytime sleepiness in patients with PD.This publication has 29 references indexed in Scilit:
- Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsyNeurology, 2000
- Daytime sleepiness in Parkinson’s diseaseJournal of Sleep Research, 2000
- Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsyAnnals of Neurology, 1998
- Methods of Testing for SleeplessnessBehavioral Medicine, 1996
- Modafinil, d‐amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperatureJournal of Sleep Research, 1995
- The measurement of fatigue: A new instrumentJournal of Psychosomatic Research, 1993
- Fatigue in Parkinson's diseaseNeurology, 1993
- The “On–Off” Phenomenon in Parkinson’s DiseaseNew England Journal of Medicine, 1984
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975
- ParkinsonismNeurology, 1967